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Abstract
Objective. The study aims to determine the preva-
lence of undiagnosed comorbid mood disorders in
patients suffering chronic musculoskeletal pain in
a primary care setting and to identify sleep dis-
turbances and other associated factors in these
patients, and to compare the use of health services
by chronic musculoskeletal pain patients with and
without comorbid mood disorders.
Design. Cross-sectional study.
Subjects. A total of 1,006 patients with chronic mus-
culoskeletal pain from a representative sample of
primary care centers were evaluated.
Outcome Measures. Pain was measured using a
visual analog scale and the Primary Care Evaluation
of Mental Disorders questionnaire was used to
measure mood disorders.
Results. We observed a high prevalence of undiag-
nosed mood disorders in chronic musculoskele-
tal pain patients (74.7%, 95% confidence interval
[CI] 71.9–77.4%), with greater comorbidity in
women (adjusted odds ratio [OR] = 1.91, 95%
CI 1.37–2.66%) and widow(er)s (adjusted OR = 1.87,
95% CI 1.19–2.91%). Both sleep disturbances
(adjusted OR = 1.60, 95% CI 1.17–2.19%) and pain
intensity (adjusted OR = 1.02, 95% CI 1.01–1.02%)
displayed a direct relationship with mood disorders.
Moreover, we found that chronic musculoskeletal
pain patients with comorbid mood disorders availed
of health care services more frequently than those
without (P < 0.001).
Conclusions. The prevalence of undiagnosed mood
disorders in patients with chronic musculoskeletal
pain is very high in primary care settings. Our find-
ings suggest that greater attention should be paid to
this condition in general practice and that sleep dis-
orders should be evaluated in greater detail to
achieve accurate diagnoses and select the most
appropriate treatment.
Key Words. Chronic Pain; Musculoskeletal; Pri-
mary Care; Sleep; Mood
Introduction
Chronic pain and depression are very frequently reported
by patients attending primary care centers [1], and they
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are often comorbid, with a prevalence ranging from 30%
to 60% [2,3]. These comorbid conditions exert a greater
negative impact on patient health than either condition
alone [2,4], and they are associated with reduced
quality of life [5,6], increased use of medical services
[7,8], and dissatisfaction with health care providers [9].
Depression is frequently undiagnosed in primary care
settings, particularly in patients suffering from chronic
pain [10,11], and consequently, this condition is under-
treated in these patients. Furthermore, the treatment of
somatic complaints often takes precedence over the
diagnosis and treatment of depression for primary care
physician [12].
Musculoskeletal disease is one of the most common
causes of severe long-term disability and protracted
chronic pain in industrialized societies [13,14]. These
pathologies have a particularly high prevalence, and they
account for up to 20% of primary health care consulta-
tions [15,16]. While a link between chronic musculoskel-
etal pain and depression has been reported [11,17], most
studies have focused on major depressive disorder (MDD)
with only a few studies addressing other mood disorders
such as minor depression, dysthymia, or bipolar disorder,
all of which are defined as mood disorders in the Diag-
nostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV). Moreover, few studies have used spe-
cific structured interviews to evaluate these conditions in a
primary care setting, and to the best of our knowledge,
undiagnosed depression has not been previously evalu-
ated in patients with chronic pain caused by musculosk-
eletal disease.
Most patients with chronic musculoskeletal pain report
poor quality sleep, and a mutually deleterious relationship
between pain and sleep disorders has been proposed.
However, this relationship remains poorly understood and
has only been characterized in patients with chronic wide-
spread pain and fibromyalgia [17–19]. Using structured
interviews, we investigated the prevalence of undiagnosed
mood disorders in patients with chronic musculoskeletal
pain in a primary care setting, and we evaluated the occur-
rence of sleep disorders in these patients. In addition, we
identified other factors that may be associated with mood
disorders, and we compared the use of health care ser-
vices by chronic musculoskeletal pain patients with and
without comorbid mood disorders.
Methods
Study Design and Sampling Process.
This cross-sectional study was carried out in primary care
centers in Spain between April and December 2006, as
part of a broader study [20]. To obtain a representative
sample, the number of primary care centers chosen in
each Spanish region was proportional to their number of
inhabitants. In each primary care center, we selected one
general practitioner (GP), who participated voluntarily,
resulting in a final sample of 600 GPs.
The study was carried out in accordance with the Helsinki
Declaration using standard working procedures and pro-
tocols, and it was approved by the Clinical Research
Ethics Committee at the Clinical and Provincial Hospital in
Barcelona, ensuring adherence to the norms of good
clinical practice.
Patient Population
The patients participating were men and women over 18
years of age who had attended their Primary Care Center
due to musculoskeletal pain that had lasted for at least 6
weeks and who had not previously been diagnosed with
any mood disorder. All participants were required to be
mentally and physically able to participate in the study, and
they provided written informed consent in advance. A total
of 1,006 patients fulfilled the earlier requirements.
Measurements
Interviews were conducted at local primary care facilities
by GPs who received written guidelines on the data col-
lection procedure. Using a structured questionnaire and
the patient’s medical records, we gathered data on socio-
demographic variables (age, sex, educational level, marital
status), clinical variables (cause, duration and intensity of
pain, location of pain, interference with daily activities due
to pain, treatment such as analgesic and/or psychotropic
medication, quality and duration of sleep), and the use of
health care resources (number of visits to a doctor and/or
hospital due to pain in the previous 6 weeks, pain-related
diagnostic tests performed in the previous 6 weeks).
The intensity of pain was measured using a visual analog
scale with a range of 0–100, with 0 corresponding to no
pain and 100 to the worst pain possible [21]. The extent
to which pain interfered with the ability to perform daily
activities and the percentage of the day spent in pain
during the previous week were also evaluated using
scales of 0–100, with 0 corresponding to no disability/no
pain and 100 corresponding to total disability/constant
pain, respectively.
To detect and evaluate mood disorders, GPs administered
the mood state module from the Spanish language
version of the Primary Care Evaluation of Mental Disorders
(PRIME-MD) questionnaire [22]. This questionnaire was
designed by Spitzer and coworkers [23] to diagnose the
most common mood disorders in a primary care setting,
and it is based on the diagnostic criteria of the DSM-IV.
The original version of the questionnaire consist of two
components, the patient questionnaire and the clinician’s
evaluation guide. The PRIME-MD Clinician Evaluation
Guide (CEG) is a structured form divided into five modules.
The 17 questions in the mood module of this question-
naire allow the clinician to reach a diagnoses of depres-
sion according to DSM-IV-text revision. Although the initial
questions in the CEG explore the symptoms experienced
in the preceding 2 weeks, the algorithm also includes
questions about the longitudinal course of symptoms that
can aid reaching diagnoses such as dysthymia. The mood
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disorders module of CEG used in the study has
been shown to have excellent positive predictive value,
with satisfactory specificity and sensitivity in terms of
diagnosis [24].
In the study, all possible PRIME-MD diagnoses according
to DSM-IV criteria were considered: MDD, minor depres-
sive disorder, partial remission from an MDD, dysthymic
disorder, bipolar disorder, and depression caused by a
general medical condition, medication, or drugs.
Data collection forms were monitored centrally to check
for missing data or inconsistencies, and corrected
where necessary.
Statistical Analysis
For descriptive analysis, absolute frequencies were cal-
culated for categorical variables, and central trend and
dispersion measurements were used for quantitative vari-
ables. The prevalence (95% confidence interval [CI])
of undiagnosed mood disorders was calculated as the
number of patients with an undiagnosed illness, as deter-
mined using the PRIME-MD questionnaire divided by the
total number of patients screened using the questionnaire.
To identify factors associated with mood disorders, we
used a logistic regression model in which the outcome
variable was the presence or absence of mood disorders,
and that included the following variables: sex, age, edu-
cational level, marital status, location of pain (neck, back,
joints, extremities), number of pain locations, intensity of
pain, duration of pain expressed as the proportion of each
day during the previous week spent in pain, current treat-
ment (non-steroidal anti-inflammatory drugs, analgesic
opioids, anxiolytics/hypnotics, other psychotropics); and
the quality and duration of sleep. Some interactions were
also tested. The variables were selected based on the
findings of the univariate analysis (P < 0.05) or their asso-
ciation with the dependent variables as described in the
literature. The Hosmer–Lemeshow test was used to
assess the goodness of fit of the model.
A bivariate analysis was performed to assess the differ-
ences between subjects with and without mood disorders
and to determine the differences in the use of health care
resources between both groups of patients.
Analyses were performed using SPSS Statistics v.17
(SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the Study Sample
Of the 1,006 patients studied, 74.5% were women, with a
mean age of 58 years (standard deviation [SD] = 12.7),
and 66.2% lived with a partner, while 74.9% had com-
pleted primary or secondary education (Table 1). The main
causes of pain were osteoarthritis (46.7%) and fibromyal-
gia (13.2%), although 6.5% of patients reported two or
more causes of pain, most commonly osteoarthritis with
osteoporosis (44.6%), followed by osteoarthritis with fibro-
myalgia (36.9%) (Figure 1). The mean duration of pain was
37.6 (SD = 50.1) months, with 96.5% of the patients suf-
fering pain for 3 months. The mean intensity of pain was
59 (SD = 19.8), and the average number of pain locations
was 3.6 (SD = 1.3), the most common of which was the
back (80.5%) (Table 2). The mean inability to perform daily
activities was 56.8 (SD = 23.3), and the mean percentage
of each day of the previous week spent in pain was 59.4
(SD = 23.3). In addition, 74.9% of patients (N = 1,002)
reported sleep disturbances due to pain, while 53.7%
(N = 998) reported being awoken by pain (Table 3). Of all
the patients studied, 88.8% took some type of analgesic
medication (Table 2).
Prevalence of Mood Disorders and Associated Factors
The prevalence of undiagnosed depression was 74.7%
(95% CI 71.9–77.4%), and this was higher in women, in
patients under 40 years of age, and in patients affected
by fibromyalgia, neck or back pain, and osteoarthritis
(Table 4). The most common mood disorder was major
depression (49.21%), followed by dysthymia (17.39%) and
minor depression (17.19%) (Figure 2).
Some important differences were observed between sub-
jects with and without comorbid mood disorders in terms
of almost all the variables analyzed, with patients with
mood disorders recording more intense pain, more pain
sites, more problems in performing daily activities, more
time in pain, and more frequent sleep disturbances
(Table 2).
Table 1 Sociodemographic characteristics of the
study sample
Variables N %
Gender (N = 974)
Male 248 25.5
Female 726 74.5






Marital status (N = 973)




Education level (N = 1,002)
No studies 148 14.8
Primary studies 532 53.1
Secondary studies 218 21.8
University studies 104 10.4
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Table 2 Characteristics of chronic musculoskeletal pain and treatment: comparison between subjects
with and without comorbid mood disorders
Variable
Total Without MD With MD
PN % N % N %
Duration of pain (months) (N = 481) (N = 118) (N = 363) 0.863‡
1.5–3 months 17 3.5 5 4.2 12 3.3
3–6 months 86 17.9 20 16.9 66 18.2
>6 months 378 78.6 93 78.8 285 78.5
Mean (SD) 37.6 (50.1) 47 (58.1) 34.5 (46.9) 0.027§
Median (P25, P75) 17 (7, 52.5) 22 (8.8, 78.5) 15 (7, 45)
Intensity of pain (VAS) (N = 1,006) (N = 255) (N = 751) <0.001§
Mean (SD) 59 (19.8) 53.5 (21.4) 60.8 (18.9)
Number of pain locations (N = 955) (N = 232) (N = 723) <0.001‡
1 67 7 28 12.1 39 5.4
2 162 17 62 26.7 100 13.8
3 or more 726 76 142 61.2 584 80.8
Mean (SD) 3.6 (1.3) 3.2 (1.4) 3.7 (1.2) <0.001§
Location of pain* (N = 955) (N = 232) (N = 723)
Neck 716 75.0 146 62.9 570 78.8 <0.001§
Back 769 80.5 159 68.5 610 84.4 <0.001§
Joints 703 73.6 151 65.1 552 76.3 0.001§
Extremities 649 68.0 151 65.1 498 68.9 0.282§
Current treatment† (N = 437) (N = 111) (N = 326)
Analgesics 388 88.8 107 96.4 281 86.2 0.003§
NSAIDs 360 82.4 102 91.9 258 79.1 0.002§
Opioids 84 19.2 17 15.3 67 20.6 0.227§
Psychotropics 216 49.4 42 37.8 174 53.4 0.005§
Anyiolytics/hypnotics 167 38.2 37 33.3 130 39.9 0.221§
Antidepressants, antipsychotics, and mood
stabilizers
81 18.5 8 7.2 73 22.4 <0.001§
* May be more than one location; † May be more than one treatment type; ‡ Chi-square test; § Mann-Whitney U test.
MD = mood disorders; NSAID = non-steroidal anti-inflammatory drug; SD = standard deviation; P25 = 25th percentile; P75 = 75th
percentile; VAS = visual analog scale.
Figure 1 Causes of chronic
musculoskeletal pain.
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The factors positively associated with the presence
of mood disorders were: being female (odds ratio
[OR] = 1.91), being a widow(er) (OR = 1.87), being
awoken due to pain (OR = 1.60), and experiencing a
greater intensity of pain (OR = 1.02) (Table 5).
The Use of Health Services by Patients with
Musculoskeletal Pain
Significant differences between patients with and without
comorbid mood disorders were only detected for the
number of visits made to primary care physicians
(P < 0.001) (Table 6).
Discussion
The most important finding of the present study was the
very high prevalence of undiagnosed mood disorders, not
only MDD, in patients with chronic musculoskeletal pain.
Factors associated with the presence of comorbid mood
disorder included female gender, being a widow(er), high
intensity pain, and sleep disruption due to pain.
The estimates available of comorbid depression in
patients suffering pain are highly variable ranging from
1.5% to 60% [2]. A study of older patients with muscu-
loskeletal pain reported a prevalence of comorbid depres-
sion of 35% [11], while symptoms of moderate depression
were reported in 19% of osteoarthritis patients [25]. Simi-
larly, prevalences of depression above 25% were found in
osteoarthritis patients [26,27], and the lifetime comorbidity
of mood disorders was reported to be 59.9% in patients
with fibromyalgia [19]. These results are consistent,
although lower than those observed in our study, where
patients with fibromyalgia showed 88.7% comorbidity.
The wide variation in these results may be due to differ-
ences in the sample populations analyzed, the method-
ologies employed and the instruments used to evaluate
mood disorders.
We assessed the presence of multiple forms of depres-
sion, some of which are less symptomatic than major
depression, and hence, they are more difficult for a GP to
detect [28]. This difficulty can lead to an underestimation
of the prevalence of comorbid mood disorders in pain
patients and may contribute to the differences between
our findings and those of previous studies.
Comorbid mood disorders were more prevalent in female
patients in agreement with previous studies in which
female gender was identified as a predictor of depression
after a 2-year follow-up in subjects with no depression at
Table 3 Impact of pain on daily activities
Variable
Total Without MD With MD P
n % n % n %
Daily activities interferences due to pain (N = 1,006) (N = 255) (N = 751)
Mean (SD) 56.8 (23.3) 48.4 (23.6) 59.7 (22.5) <0.001*
Duration (% of day in pain in the last week) (N = 1,006) (N = 255) (N = 751)
Mean (SD) 59.4 (23.3) 51.3 (25.1) 62.2 (22.0) <0.001*
Loss of sleep due to pain
Yes 1,002 74.9 253 64.4 749 78.4 <0.001†
Awoken due to pain
Yes 998 53.7 252 42.5 746 57.5 <0.001†
* Mann-Whitney U test; † Chi-square test.
MD = mood disorders; SD = standard deviation.
Table 4 Prevalence (95% confidence interval [CI])
of mood disorders according to gender, age, and
cause of pain
N Prevalence 95% CI
Global 1,006 74.7 (71.9–77.4)
Gender
Male 248 62.5 (56.3–68.7)
Female 726 78.7 (75.6–81.7)
Age
<40 69 82.6 (72.9–92.3)
40–49 150 75.3 (68.1–82.6)
50–59 257 71.2 (65.4–76.9)
60–69 220 76.4 (70.5–82.2)
70+ 166 72.9 (65.8–79.9)
Cause of pain
Osteoarthritis 470 75.1 (71.1–79.1)
Fibromyalgia 133 88.7 (83.0–94.5)
Herniated disk 61 65.6 (52.8–78.3)
Neck or back pain 52 78.8 (66.8–90.9)
Osteoporosis 25 72 (52.4–91.6)
Contracture 49 67.3 (53.2–81.5)
Arthritis 35 57.1 (39.3–75.0)
Dorsopathy 46 69.6 (55.2–83.9)
Other causes 70 62.9 (50.8–74.9)





baseline [29]. While differences in the reporting of pain
between women and men are partly attributable to social
conditioning and psychosocial factors, such as pain
beliefs, coping, and self-efficacy [30], several studies
suggest that biological mechanisms may also contribute
to this situation [31]. An analysis of sex differences in
pain-related disability among patients with musculoskel-
etal pain demonstrated that women report greater pain
intensity and pain-related disability than men, even after
controlling for depression, anxiety, and other psychologi-
cal variables such as self-efficacy [30]. It is plausible that
biological and psychosocial influences may predispose
males and females to different coping strategies, and
indeed, women report a higher degree of catastrophizing
than men [32,33]. In a review of pain-related sex differ-
ences, substantial differences in clinical and experimental
pain responses were reported, and the potential underly-
ing mechanisms were discussed, implicating gonadal hor-
mones, endogenous pain modulatory systems, gender
roles, and cognitive/affective factors [34].
We found that pain intensity was associated with the
presence of comorbid mood disorders, although no such
association was detected for the number of pain loca-
tions, consistent with previous reports [35]. However,
these observations differ from those of Gureje and
coworkers, who failed to report an association between
the intensity of pain and the severity of depression, but
observed a relationship between the number of pain sites
and the presence of comorbid mood disorders [36]. It
should be noted, however, that the latter study analyzed
the general population and not primary care patients.
Comorbid depression in pain patients contributes signifi-
cantly to poorer outcomes and increased cost of treat-
ment, highlighting the need for a greater understanding of
the relationship between pain and depression.
It has been suggested that there are certain connections
between depression and chronic pain, as endorsed in
several preclinical and clinical studies [37,38]. In fact, the
main noradrenergic and serotonergic nuclei in the central
nervous system, the locus coeruleus and the dorsal raphe
magnus, respectively, are closely associated to the neu-
robiological mechanisms responsible for the chronicity of
pain and the provocation of mood disorders, particularly
depression [39,40].
In addition, it is well known that antidepressants that
enhance the availability of noradrenaline and serotonin at
the level of the synaptic cleft have demonstrated analgesic
properties, as well as antidepressant activity [41–44].
Figure 2 Prevalence of each
type of mood disorders.
Table 5 Binary logistic regression model for the
presence of mood disorders in patients with
chronic musculoskeletal pain (N = 411)
Variables B OR P 95% CI
Sex
Male*
Female 0.65 1.91 <0.001 (1.37–2.66)
Marital status
Living with partner*
Divorced/separated 0.52 1.68 0.088 (0.93–3.09)
Single -0.15 0.86 0.652 (0.44–1.67)
Widow(er) 0.62 1.87 0.006 (1.19–2.91)
Awoken due to pain
No*
Yes 0.47 1.60 0.003 (1.17–2.19)
Intensity of pain 0.02 1.02 <0.001 (1.01–1.02)
* Reference category.
Hosmer-Lemeshow: c2 = 4.714; d.f. = 8; P = 0.788.
Dependent variable: Presence of mood disorders.
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Furthermore, pain modulation is impaired in depressed
patients [45,46] probably due to enhanced emotionality,
as measured by neuroimanging techniques [46–48].
The link between sleep disturbances and chronic pain
described here may have been overestimated due to self-
reporting. However, this link is supported by several
studies proposing a reciprocal relationship between these
phenomena [18,49]. Chronic pain is also associated with
a greater number of insomnia symptoms, more severe
daytime consequences, and increased chronicity of
insomnia [50]. A recent review proposed that sleep distur-
bances and sleep restrictions result in musculoskeletal
pain and increased sensitivity to noxious stimuli [51], while
clinical and epidemiological studies have demonstrated a
direct influence of sleep disturbances on musculoskeletal
pain, fatigue, mood, and overall well-being. Moreover, the
relationship between the brain sleep-wake cycle, and
cytokine and cellular immune functions, has important
implications for the understanding of rheumatic disease
pathology and its management with anti-rheumatic drugs.
We found that comorbid mood disorders and pain are
associated with increased use of health care resources,
particularly primary care consultations. This could be
explained by the mood disorder reducing the pain thresh-
old and tolerance, increasing the risk of persistent long-
term pain and producing less pain relief through
medication [52]. Accordingly, many GPs regard depres-
sion and anxiety as the most significant and problema-
tic complications when treating patients with chronic
pain [53].
Several limitations of the present study should be borne in
mind when considering our findings. First, we did not
assess the coincidence of other chronic medical or psychi-
atric conditions, such as anxiety, which are frequently
associated with depression and often prevalent among
chronic pain patients [54,55]. Indeed, an association
between pain, anxiety, and depression has been reported
[55], and the probability of suffering chronic or multiple pain
increases in cases of comorbid depression and anxiety,
when compared with either condition alone. Second, our
survey was conducted as a cross-sectional study and
consequently provides no information regarding the direc-
tion of causality between chronic pain andmood disorders.
Thus, we can only postulate as to how the association
between pain and mood is established. Finally, the present
study may involve a bias due to the lack of diagnostic
confirmation by means of a larger structured psychiatric
interview. Nonetheless, the PRIME-MD used is an instru-
ment with tried and tested psychometric properties, and it
has proven diagnostic validity in a primary care setting.
It should be noted that this study forms part of another
larger study that included patients with pain that had been
experienced for at least 6 weeks. Although this criterion
does not adjust to the International Association for the
Study of Pain (IASP) definition based on the persistence of
pain for 12 weeks, it was used as 6 weeks was consid-
ered sufficient time to exclude patients with acute pain. In
this sense, it should be noted that the criterion of duration
is not the only factor that should be considered when
defining chronic pain, as indicated by the American
Society of Anesthesiologist’s Task Force on Chronic Pain
Management and the American Society of Regional Anes-
thesia and Pain Medicine [56]. Nevertheless, almost all the
patients with pain in this study referred to a duration of
pain for at least 3 months.
A key strength of the present study is that our results are
based on a large dataset collected from a wide range of
Table 6 The use of health services by chronic musculoskeletal pain patients with and without comorbid
mood disorders
Variables Total Without MD With MD P*
Number of visits to the GP due to pain in the last
6 weeks.
N = 927 N = 224 N = 703
Mean (SD) 3.20 (1.98) 2.75 (2.26) 3.35 (1.86) <0.001
Median (P25; P75) 3.0 (2.0; 4.0) 2.0 (2.0; 3.0) 3.0 (2.0; 4.0)
Number of visits to a specialist due to pain in the last
6 weeks
N = 447 N = 87 N = 360
Mean (SD) 1.18 (1.38) 1.15 (1.66) 1.19 (1.31) 0.280
Median (P25; P75) 1.0 (1.0; 1.0) 1.0 (1.0; 1.0) 1.0 (1.0; 1.0)
Number of diagnostic tests for pain in the last 6 weeks N = 513 N = 117 N = 396
Mean (SD) 1.49 (1.04) 1.48 (1.21) 1.49 (0.98) 0.602
Median (P25; P75) 1.0 (1.0; 2.0) 1.0 (1.0; 2.0) 1.0 (1.0; 2.0)
Number of hospitalizations due to pain in the last year. N = 199 N = 43 N = 156
Mean (SD) 0.45 (1.03) 0.26 (0.49) 0.51 (1.13) 0.306
Median (P25; P75) 0.0 (0.0; 1.0) 0.0 (0.0; 0.0) 0.0 (0.0; 1.0)
* Wilcoxon Test.
MD = mood disorders; SD = standard deviation; P25 = 25th percentile; P75 = 75th percentile.
1422
Salazar et al.
primary care centers where GPs perform their usual clini-
cal work. Furthermore, mood disorders were diagnosed
using internationally validated criteria.
Conclusions
In conclusion, we observed a very high prevalence of
undiagnosed mood disorders in chronic musculoskeletal
pain patients that visit their primary care physician. Detec-
tion and treatment of depression and rigorous assessment
of sleep disturbances may improve the health status of
these patients, as well as providing further pain relief and
decreasing the associated disease burden and health
care costs.
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